TCIM
BIIB icon

TIAA CREF Investment Management’s Biogen BIIB Stock Holding History

TIAA CREF Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$216M Buy
913,931
+59,423
+7% +$18.7M 0.15% 135
2018
Q4 		$257M Sell
854,508
-119,317
-12% -$38.1M 0.2% 101
2018
Q3 		$344M Sell
973,825
-74,333
-7% -$25.6M 0.22% 97
2018
Q2 		$304M Sell
1,048,158
-308,448
-23% -$86.7M 0.2% 108
2018
Q1 		$371M Sell
1,356,606
-28,210
-2% -$8.76M 0.25% 87
2017
Q4 		$441M Sell
1,384,816
-721,682
-34% -$232M 0.29% 73
2017
Q3 		$660M Buy
2,106,498
+199,678
+10% +$59.1M 0.45% 47
2017
Q2 		$517M Buy
1,906,820
+426,821
+29% +$113M 0.36% 57
2017
Q1 		$405M Buy
1,479,999
+98,956
+7% +$28M 0.29% 73
2016
Q4 		$392M Sell
1,381,043
-168,255
-11% -$49.9M 0.29% 76
2016
Q3 		$485K Buy
1,549,298
+155,756
+11% +$46.1M 0.3% 73
2016
Q2 		$337M Sell
1,393,542
-134,535
-9% -$35.5M 0.26% 84
2016
Q1 		$398M Sell
1,528,077
-132,901
-8% -$35.1M 0.3% 75
2015
Q4 		$509M Sell
1,660,978
-305,310
-16% -$87.7M 0.38% 57
2015
Q3 		$574M Sell
1,966,288
-175,224
-8% -$57.9M 0.45% 46
2015
Q2 		$865M Buy
2,141,512
+470,529
+28% +$189M 0.61% 30
2015
Q1 		$706M Sell
1,670,983
-401,883
-19% -$158M 0.49% 41
2014
Q4 		$704M Sell
2,072,866
-330,096
-14% -$107M 0.49% 38
2014
Q3 		$795M Sell
2,402,962
-241,366
-9% -$79.6M 0.57% 31
2014
Q2 		$834M Sell
2,644,328
-288,701
-10% -$86.9M 0.58% 29
2014
Q1 		$897M Sell
2,933,029
-25,991
-0.9% -$8.25M 0.65% 26
2013
Q4 		$828M Sell
2,959,020
-163,286
-5% -$42.2M 0.59% 26
2013
Q3 		$752M Buy
3,122,306
+134,985
+5% +$30.2M 0.59% 32
2013
Q2 		$643M Buy
+2,987,321
New +$638M 0.52% 35

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's BIIB Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Biogen (BIIB) stake by 7% in Q1 2019, buying an estimated $18.7M and bringing the position to 913,931 shares worth $216M. The position accounts for 0.15% of the portfolio, ranked #135.

TIAA CREF Investment Management first reported a position in BIIB in Q2 2013 and has held it in 24 quarters since. The position peaked at $897M in Q1 2014. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • TIAA CREF Investment Management held 913,931 shares of Biogen worth $216M as of Q1 2019.
  • TIAA CREF Investment Management bought 59,423 Biogen shares in Q1 2019, an estimated $18.7M.
  • Biogen made up 0.15% of TIAA CREF Investment Management's portfolio in Q1 2019, its #135 holding.
  • TIAA CREF Investment Management first reported a position in Biogen in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Biogen position peaked at $897M in Q1 2014.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.